« Previous
Next »
Seminars in Nephrology
Volume 27, Issue 5
, Pages 509-510
, September 2007
Hypertension and the Kidney: New Avenues for an Improved Management of Hypertension in Renal Diseases: Introduction
References
- Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252
- K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(Suppl 1):S1–S290
- Prevalence of high blood pressure and elevated serum creatinine level in the United States: finding from the third national Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2001;161:1207–1216
- . Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20/8:1461–1464
- Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417–1427
- Contribution of non–proteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol. 2006;17:2495–2503
- . Aliskiren for renin inhibition: a new class of antihypertensives. Ann Pharmacother. 2007;41:456–464
- . Resistant hypertension, obesity, sleep apnea and aldosterone. Theory and therapy. Hypertension. 2004;43:518–524
- . Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:1175–1180
- . Hypothesis on renal mechanism of non–dipper pattern of circadian blood pressure rhythm. Med Hypotheses. 2006;67:802–806
PII: S0270-9295(07)00089-7
doi: 10.1016/j.semnephrol.2007.07.008
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Nephrology
Volume 27, Issue 5
, Pages 509-510
, September 2007
